Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Merck, KGaA, Darmstadt, Germany's cross-business effort to stem the tide of Zika in Latin America

In light of the ongoing Zika virus epidemic in Latin America, Merck, KGaA, Darmstadt, Germany is in close contact with governments and militaries of Brazil and Colombia to support and discuss possible alternatives on prevention. We are further investigating the effectiveness of IR3535, our insect repellent, in a variety of settings. Merck, KGaA, Darmstadt, Germany's Performance Material and Government Affairs teams are coordinating with the army to monitor their tests with DEET and IR3535. IR3535, in other studies, has been shown to be the best indication for pregnant women due to its reduced allergy effects.


Diabetes Academy in Yemen

In 2014, Merck, KGaA, Darmstadt, Germany implemented the Diabetes Academy program in Yemen, an initiative committed at educating health care practitioners about the latest diabetes management guidelines. The successful Diabetes Academy program, endorsed by the Yemen Diabetes Society, comprises lectures, group meetings and 12 modules to deliver key messages to doctors, thus enhancing awareness and accessibility of knowledge for better patient outcomes.


e-Health initiative in Kenya

In partnership with the Kenyan Ministry of Health, Merck, KGaA, Darmstadt, Germany has launched an e-Health initiative, opening two e-health clinics in Kenya to improve access to cancer care. The initiative allows patients and healthcare providers in remote areas to interact with specialists from a referral hospital conferencing technologies. Thus, Merck, KGaA, Darmstadt, Germany provides patients with direct access to effective medical therapies. The next phase of the initiative will include upgrading telemedicine capabilities to enable digital patient examination.


Thyroid Awareness Program in Indonesia

Merck, KGaA, Darmstadt, Germany has implemented a Public-Private Partnership to conduct an awareness program on Thyroid disease via seminars. Merck, KGaA, Darmstadt, Germany has launched training workshops in 6 different cities in order to educate primary care physicians and specialists on thyroid disease for early detection and management.


Initiatives by Region

Search initiatives by Region


Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.